Stocklytics Platform
Asset logo for symbol FHTX
Foghorn Therapeutics
FHTX57
$6.20arrow_drop_down2.51%-$0.16
Asset logo for symbol FHTX
FHTX57

$6.20

arrow_drop_down2.51%

AI Deep-Learning Forecast (FHTX)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Foghorn Therapeutics (FHTX) Stocklytics Forecast

Foghorn Therapeutics Inc (FHTX) is a biotechnology company that is focused on discovering and developing novel therapeutics targeting the chromatin regulatory system. The company's proprietary Gene Traffic Control platform enables the identification of new targets and the development of small molecule modulators of gene expression. Foghorn Therapeutics aims to address unmet medical needs in diseases that are driven by dysregulation of gene expression.

Investing in Foghorn Therapeutics Inc (FHTX) stock can be a promising opportunity for long-term investors. The company has a strong pipeline of potential therapeutics and is backed by a team of experienced scientists and entrepreneurs. Foghorn Therapeutics' focus on the chromatin regulatory system presents a unique approach to addressing diseases at the root cause. With advancements in genomics and an increasing understanding of the role of chromatin regulation in disease, Foghorn Therapeutics is well-positioned for future success.

add Foghorn Therapeutics  to watchlist

Keep an eye on Foghorn Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for Foghorn Therapeutics (FHTX) stock?

Analysts have set a target price of $18.25 for Foghorn Therapeutics (FHTX), based on forecasts from 20 analysts. The predicted price range extends from a high of $26 to a low of $6. This represents a potential increase of up to 318.69% and a decrease of -3.38% from the current price of $6.21. These forecasts are as of 2020 Nov 17.

help
What are the analyst ratings for Foghorn Therapeutics (FHTX) stock?

Currently, there are no analyst ratings available for Foghorn Therapeutics (FHTX), possibly due to insufficient coverage or recent updates.

help
What is the AI price prediction for Foghorn Therapeutics (FHTX) stock?

At present, there is no AI or machine-learning-based price prediction available for Foghorn Therapeutics (FHTX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level